Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Mimedx (MDXG) Receivables - Other (2017 - 2021)

Mimedx's Receivables - Other history spans 5 years, with the latest figure at $400000.0 for Q2 2021.

  • For Q2 2021, Receivables - Other changed N/A year-over-year to $400000.0; the TTM value through Jun 2021 reached $400000.0, changed N/A, while the annual FY2020 figure was $200000.0, 84.62% down from the prior year.
  • Receivables - Other for Q2 2021 was $400000.0 at Mimedx, up from $100000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $5.9 million in Q4 2017 and bottomed at $100000.0 in Q1 2021.
  • The 5-year median for Receivables - Other is $950000.0 (2019), against an average of $1.9 million.
  • The largest annual shift saw Receivables - Other fell 27.12% in 2018 before it tumbled 84.62% in 2020.
  • A 5-year view of Receivables - Other shows it stood at $5.9 million in 2017, then dropped by 27.12% to $4.3 million in 2018, then tumbled by 69.77% to $1.3 million in 2019, then crashed by 84.62% to $200000.0 in 2020, then skyrocketed by 100.0% to $400000.0 in 2021.
  • Per Business Quant, the three most recent readings for MDXG's Receivables - Other are $400000.0 (Q2 2021), $100000.0 (Q1 2021), and $200000.0 (Q4 2020).